Results 241 to 246 of about 157,234 (246)

Version 3 of the Alzheimer Disease Centers’ neuropsychological test battery in the Uniform Data Set (UDS) [PDF]

, 2018
al., et, Morris, John C., Weintraub, Sandra   +2 more
core   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer’s Disease

Current Drug Targets, 2020
openaire   +1 more source

Angiotensin-Receptor Blockers and the Risk of Alzheimer´s Disease: A Meta-analysis

Current Reviews in Clinical and Experimental Pharmacology, 2021
openaire   +1 more source

Expression of LIF and LIF receptor beta in Alzheimer’s and Parkinson’s diseases

Acta Neurologica Scandinavica, 2010
M. Soilu-Hänninen, E. Broberg, M. Röyttä, P. Mattila, J. Rinne, V. Hukkanen   +5 more
openaire   +1 more source

AN ANCIENT APPROACH BUT TURNING INTO FUTURE POTENTIAL SOURCE OF THERAPEUTICS IN ALZHEIMER’S DISEASE

International Research Journal of Pharmacy, 2015
openaire   +1 more source

Hydrophobic Nanocrystals of Donepezil for Sustained Release in Alzheimer’s Disease In Vitro/In Vivo Evaluation

2016
openaire   +1 more source